Critical appraisal of "Goetz G, Wernly B, Wild C (2023) Wearable cardioverter defibrillator for preventing sudden cardiac death in patients at risk: An updated systematic review of comparative effectiveness and safety. IJC Heart & Vasculature 45 (2023) 101189"
- PMID: 37680548
- PMCID: PMC10480618
- DOI: 10.1016/j.ijcha.2023.101258
Critical appraisal of "Goetz G, Wernly B, Wild C (2023) Wearable cardioverter defibrillator for preventing sudden cardiac death in patients at risk: An updated systematic review of comparative effectiveness and safety. IJC Heart & Vasculature 45 (2023) 101189"
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
-
- G. Goetz, B. Wernly, Wearable cardioverter-defibrillator (WCD) therapy for primary and secondary prevention of sudden cardiac arrest. Update 2022. Decision Support Document 103/ 2. Update 2022.: 2022 [cited 24.10.2022]. Available from: https://eprints.aihta.at/1407/.
-
- Weiss M., Michels G., Eberhardt F., Fehske W., Winter S., Baer F., Choi Y.-H., Albus C., Steven D., Baldus S., Pfister R., Andò G. Anxiety, depression and quality of life in acute high-risk cardiac disease patients eligible for wearable cardioverter defibrillator: Results from the prospective multicenter CREDregistry. PLoS ONE. 2019;14(3):e0213261. - PMC - PubMed
-
- Institute of Health Economics (IHE), Quality Appraisal Checklist for Case Series [cited 01.07.2022]. Available from: https://www.ihe.ca/research-programs/rmd/cssqac/cssqac-about, 2016.
-
- Balshem H., Helfand M., Schünemann H.J., Oxman A.D., Kunz R., Brozek J., Vist G.E., Falck-Ytter Y., Meerpohl J., Norris S. GRADE guidelines: 3. Rating the quality of evidence. J. Clin. Epidemiol. 2011;64(4):401–406. - PubMed
LinkOut - more resources
Full Text Sources